×
This post has expired! It was posted more than 90 days ago.

Promoted Listing

<- Back

Biosimilar medicines: A general practice update

  • : Online

Biosimilar medicines are becoming increasingly available in Australia, but misconceptions surrounding them exist among both patients and prescribers. This activity seeks to support primary care practitioners’ safe and effective use of these medications, and develop patient and prescriber confidence through education and evidence-based decision making.

On completion of this education activity participants will be able to:

  • Understand the principles behind biological medicines, including biosimilars.
  • Outline the clinical development and regulatory processes required prior to approval of biosimilar medicines.
  • Define the criteria that must be met in order to substitute a PBS-subsidised reference biological for a biosimilar medicine.
  • Explain to patients what a biosimilar medicine is, why it is different to a generic medicine, and their therapeutic equivalence to the reference biological product.
  • Manage patient concerns and queries surrounding biosimilar medicines.

This activity is sponsored by GBMA Education.

Content partners: 

GBMA Education

 

This education is designed to take 1 hour to complete. It does not need to be completed in one sitting. You can stop at any time, and progress will be saved. 

If you need any assistance or have any feedback about this education, please contact our helpdesk at thinkgp(at)reedexhibitions.com.au

Click here for more information


PRM123
Delivery
Title
Biosimilar medicines: A general practice update
Interest Areas / Topics Covered
Chronic Conditions and Disease Management
Location
Provider Type
RTO
End Date
06-Dec-2020
CPD Points
RACGP: 2pts | ACRRM: 1hr
Price
Free
Location
Online
Posted By
Contact Phone
1800 571 960
HealthcareLink